Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

4.12
Delayed Data
As of 4:00pm ET
 +0.06 / +1.48%
Today’s Change
3.05
Today|||52-Week Range
9.72
-31.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues424.0K139.0K222.0K205.0K
 
 
 
 
 
Depreciation And Amortization53.0K42.0K33.0K34.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses4.2M3.8M3.9M3.6M
 
 
 
 
 
Research And Development2.5M2.5M2.6M2.4M
 
 
 
 
 
Total Operating Expenses4.3M3.9M4.0M3.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-3.7M-3.8M-3.5M
 
 
 
 
 
Other Expenses-15.0K200.0K156.0K69.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.9M-3.5M-3.6M-3.4M
 
 
 
 
 
Income Taxes-498.0K-493.0K-626.0K-454.0K
 
 
 
 
 
Preferred Dividend-51.0K-50.0K-50.0K-50.0K
 
 
 
 
 
Net Income-3.4M-3.0M-3.0M-2.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.9M3.0M3.0M3.5M
 
 
 
 
 
Shares To Calculate EPS Diluted2.9M3.0M3.0M3.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.20-$1.08-$1.01-$0.86
 
 
 
 
 
EPS Diluted-$1.20-$1.08-$1.00-$0.86